nodes	percent_of_prediction	percent_of_DWPC	metapath
Protriptyline—ABCB1—Mitomycin—urinary bladder cancer	0.297	0.474	CbGbCtD
Protriptyline—ABCB1—Gemcitabine—urinary bladder cancer	0.0854	0.136	CbGbCtD
Protriptyline—ABCB1—Cisplatin—urinary bladder cancer	0.062	0.0991	CbGbCtD
Protriptyline—ABCB1—Etoposide—urinary bladder cancer	0.0609	0.0974	CbGbCtD
Protriptyline—ABCB1—Doxorubicin—urinary bladder cancer	0.0416	0.0664	CbGbCtD
Protriptyline—ABCB1—Methotrexate—urinary bladder cancer	0.0403	0.0643	CbGbCtD
Protriptyline—CYP2D6—Doxorubicin—urinary bladder cancer	0.0392	0.0626	CbGbCtD
Protriptyline—Carbamazepine—UGT2B7—urinary bladder cancer	0.00311	0.813	CrCbGaD
Protriptyline—ABCB1—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00189	0.0943	CbGpPWpGaD
Protriptyline—CYP2D6—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00179	0.0889	CbGpPWpGaD
Protriptyline—SLC6A2—Amine compound SLC transporters—SLC14A2—urinary bladder cancer	0.00163	0.0813	CbGpPWpGaD
Protriptyline—CYP2D6—Miscellaneous substrates—CYP4B1—urinary bladder cancer	0.00116	0.0579	CbGpPWpGaD
Protriptyline—CYP2D6—Fatty acids—CYP4B1—urinary bladder cancer	0.000972	0.0484	CbGpPWpGaD
Protriptyline—CYP2D6—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.000825	0.0411	CbGpPWpGaD
Protriptyline—Confusional state—Fluorouracil—urinary bladder cancer	0.000752	0.00215	CcSEcCtD
Protriptyline—Convulsion—Cisplatin—urinary bladder cancer	0.00075	0.00214	CcSEcCtD
Protriptyline—Oedema—Fluorouracil—urinary bladder cancer	0.000746	0.00213	CcSEcCtD
Protriptyline—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000743	0.00212	CcSEcCtD
Protriptyline—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000743	0.00212	CcSEcCtD
Protriptyline—Ataxia—Methotrexate—urinary bladder cancer	0.000742	0.00212	CcSEcCtD
Protriptyline—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000736	0.0021	CcSEcCtD
Protriptyline—Anxiety—Cisplatin—urinary bladder cancer	0.000735	0.0021	CcSEcCtD
Protriptyline—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00073	0.00209	CcSEcCtD
Protriptyline—Discomfort—Cisplatin—urinary bladder cancer	0.000729	0.00208	CcSEcCtD
Protriptyline—Tachycardia—Fluorouracil—urinary bladder cancer	0.000728	0.00208	CcSEcCtD
Protriptyline—Anorexia—Gemcitabine—urinary bladder cancer	0.000723	0.00206	CcSEcCtD
Protriptyline—Phenylbutazone—PTGS2—urinary bladder cancer	0.000717	0.187	CrCbGaD
Protriptyline—Urticaria—Thiotepa—urinary bladder cancer	0.000716	0.00205	CcSEcCtD
Protriptyline—Malaise—Etoposide—urinary bladder cancer	0.000716	0.00204	CcSEcCtD
Protriptyline—Abdominal pain—Thiotepa—urinary bladder cancer	0.000713	0.00204	CcSEcCtD
Protriptyline—Body temperature increased—Thiotepa—urinary bladder cancer	0.000713	0.00204	CcSEcCtD
Protriptyline—Anorexia—Fluorouracil—urinary bladder cancer	0.000711	0.00203	CcSEcCtD
Protriptyline—Leukopenia—Etoposide—urinary bladder cancer	0.00071	0.00203	CcSEcCtD
Protriptyline—Purpura—Doxorubicin—urinary bladder cancer	0.000709	0.00202	CcSEcCtD
Protriptyline—Hypotension—Gemcitabine—urinary bladder cancer	0.000709	0.00202	CcSEcCtD
Protriptyline—Oedema—Cisplatin—urinary bladder cancer	0.000707	0.00202	CcSEcCtD
Protriptyline—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	0.000697	0.00199	CcSEcCtD
Protriptyline—Hypotension—Fluorouracil—urinary bladder cancer	0.000697	0.00199	CcSEcCtD
Protriptyline—Ataxia—Epirubicin—urinary bladder cancer	0.000694	0.00198	CcSEcCtD
Protriptyline—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000692	0.00198	CcSEcCtD
Protriptyline—Tachycardia—Cisplatin—urinary bladder cancer	0.00069	0.00197	CcSEcCtD
Protriptyline—Convulsion—Etoposide—urinary bladder cancer	0.000687	0.00196	CcSEcCtD
Protriptyline—Insomnia—Gemcitabine—urinary bladder cancer	0.000686	0.00196	CcSEcCtD
Protriptyline—Hypertension—Etoposide—urinary bladder cancer	0.000685	0.00196	CcSEcCtD
Protriptyline—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000681	0.00194	CcSEcCtD
Protriptyline—Eosinophilia—Methotrexate—urinary bladder cancer	0.000675	0.00193	CcSEcCtD
Protriptyline—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.000675	0.00193	CcSEcCtD
Protriptyline—Insomnia—Fluorouracil—urinary bladder cancer	0.000674	0.00193	CcSEcCtD
Protriptyline—Somnolence—Gemcitabine—urinary bladder cancer	0.000674	0.00193	CcSEcCtD
Protriptyline—Anorexia—Cisplatin—urinary bladder cancer	0.000674	0.00192	CcSEcCtD
Protriptyline—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00067	0.00191	CcSEcCtD
Protriptyline—CYP2D6—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.000669	0.0333	CbGpPWpGaD
Protriptyline—Discomfort—Etoposide—urinary bladder cancer	0.000667	0.00191	CcSEcCtD
Protriptyline—Somnolence—Fluorouracil—urinary bladder cancer	0.000663	0.00189	CcSEcCtD
Protriptyline—Hypotension—Cisplatin—urinary bladder cancer	0.000661	0.00189	CcSEcCtD
Protriptyline—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000659	0.00188	CcSEcCtD
Protriptyline—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000656	0.00187	CcSEcCtD
Protriptyline—Fatigue—Gemcitabine—urinary bladder cancer	0.000654	0.00187	CcSEcCtD
Protriptyline—Confusional state—Etoposide—urinary bladder cancer	0.000653	0.00186	CcSEcCtD
Protriptyline—Constipation—Gemcitabine—urinary bladder cancer	0.000649	0.00185	CcSEcCtD
Protriptyline—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000648	0.00185	CcSEcCtD
Protriptyline—Pancytopenia—Methotrexate—urinary bladder cancer	0.000648	0.00185	CcSEcCtD
Protriptyline—Asthenia—Thiotepa—urinary bladder cancer	0.000647	0.00185	CcSEcCtD
Protriptyline—Ataxia—Doxorubicin—urinary bladder cancer	0.000643	0.00184	CcSEcCtD
Protriptyline—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000639	0.0318	CbGpPWpGaD
Protriptyline—Pruritus—Thiotepa—urinary bladder cancer	0.000638	0.00182	CcSEcCtD
Protriptyline—Paraesthesia—Cisplatin—urinary bladder cancer	0.000635	0.00181	CcSEcCtD
Protriptyline—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000634	0.00181	CcSEcCtD
Protriptyline—Tachycardia—Etoposide—urinary bladder cancer	0.000632	0.00181	CcSEcCtD
Protriptyline—Eosinophilia—Epirubicin—urinary bladder cancer	0.000632	0.0018	CcSEcCtD
Protriptyline—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000628	0.00179	CcSEcCtD
Protriptyline—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000625	0.00178	CcSEcCtD
Protriptyline—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.000624	0.00178	CcSEcCtD
Protriptyline—Anorexia—Etoposide—urinary bladder cancer	0.000617	0.00176	CcSEcCtD
Protriptyline—Diarrhoea—Thiotepa—urinary bladder cancer	0.000617	0.00176	CcSEcCtD
Protriptyline—Decreased appetite—Cisplatin—urinary bladder cancer	0.000614	0.00175	CcSEcCtD
Protriptyline—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000614	0.00175	CcSEcCtD
Protriptyline—Drowsiness—Methotrexate—urinary bladder cancer	0.000608	0.00174	CcSEcCtD
Protriptyline—Pancytopenia—Epirubicin—urinary bladder cancer	0.000606	0.00173	CcSEcCtD
Protriptyline—Hypotension—Etoposide—urinary bladder cancer	0.000605	0.00173	CcSEcCtD
Protriptyline—Body temperature increased—Gemcitabine—urinary bladder cancer	0.0006	0.00171	CcSEcCtD
Protriptyline—Dizziness—Thiotepa—urinary bladder cancer	0.000596	0.0017	CcSEcCtD
Protriptyline—Stomatitis—Methotrexate—urinary bladder cancer	0.000593	0.00169	CcSEcCtD
Protriptyline—Urticaria—Fluorouracil—urinary bladder cancer	0.000592	0.00169	CcSEcCtD
Protriptyline—Pollakiuria—Epirubicin—urinary bladder cancer	0.00059	0.00168	CcSEcCtD
Protriptyline—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000589	0.00168	CcSEcCtD
Protriptyline—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000585	0.00167	CcSEcCtD
Protriptyline—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000583	0.00166	CcSEcCtD
Protriptyline—Paraesthesia—Etoposide—urinary bladder cancer	0.000582	0.00166	CcSEcCtD
Protriptyline—Weight increased—Epirubicin—urinary bladder cancer	0.000581	0.00166	CcSEcCtD
Protriptyline—Somnolence—Etoposide—urinary bladder cancer	0.000576	0.00164	CcSEcCtD
Protriptyline—Vomiting—Thiotepa—urinary bladder cancer	0.000573	0.00164	CcSEcCtD
Protriptyline—Drowsiness—Epirubicin—urinary bladder cancer	0.000569	0.00163	CcSEcCtD
Protriptyline—Rash—Thiotepa—urinary bladder cancer	0.000568	0.00162	CcSEcCtD
Protriptyline—Dermatitis—Thiotepa—urinary bladder cancer	0.000568	0.00162	CcSEcCtD
Protriptyline—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000568	0.00162	CcSEcCtD
Protriptyline—Headache—Thiotepa—urinary bladder cancer	0.000565	0.00161	CcSEcCtD
Protriptyline—Decreased appetite—Etoposide—urinary bladder cancer	0.000563	0.00161	CcSEcCtD
Protriptyline—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000561	0.0016	CcSEcCtD
Protriptyline—Body temperature increased—Cisplatin—urinary bladder cancer	0.000559	0.0016	CcSEcCtD
Protriptyline—Fatigue—Etoposide—urinary bladder cancer	0.000558	0.00159	CcSEcCtD
Protriptyline—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000558	0.00159	CcSEcCtD
Protriptyline—Stomatitis—Epirubicin—urinary bladder cancer	0.000555	0.00158	CcSEcCtD
Protriptyline—Jaundice—Epirubicin—urinary bladder cancer	0.000555	0.00158	CcSEcCtD
Protriptyline—Constipation—Etoposide—urinary bladder cancer	0.000554	0.00158	CcSEcCtD
Protriptyline—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000546	0.00156	CcSEcCtD
Protriptyline—Asthenia—Gemcitabine—urinary bladder cancer	0.000544	0.00155	CcSEcCtD
Protriptyline—Weight increased—Doxorubicin—urinary bladder cancer	0.000538	0.00154	CcSEcCtD
Protriptyline—Pruritus—Gemcitabine—urinary bladder cancer	0.000537	0.00153	CcSEcCtD
Protriptyline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000536	0.0267	CbGpPWpGaD
Protriptyline—Nausea—Thiotepa—urinary bladder cancer	0.000536	0.00153	CcSEcCtD
Protriptyline—Feeling abnormal—Etoposide—urinary bladder cancer	0.000534	0.00152	CcSEcCtD
Protriptyline—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000531	0.00152	CcSEcCtD
Protriptyline—Pruritus—Fluorouracil—urinary bladder cancer	0.000528	0.00151	CcSEcCtD
Protriptyline—Drowsiness—Doxorubicin—urinary bladder cancer	0.000527	0.0015	CcSEcCtD
Protriptyline—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000519	0.00148	CcSEcCtD
Protriptyline—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000516	0.00147	CcSEcCtD
Protriptyline—Urticaria—Etoposide—urinary bladder cancer	0.000514	0.00147	CcSEcCtD
Protriptyline—Stomatitis—Doxorubicin—urinary bladder cancer	0.000513	0.00147	CcSEcCtD
Protriptyline—Jaundice—Doxorubicin—urinary bladder cancer	0.000513	0.00147	CcSEcCtD
Protriptyline—Abdominal pain—Etoposide—urinary bladder cancer	0.000512	0.00146	CcSEcCtD
Protriptyline—Body temperature increased—Etoposide—urinary bladder cancer	0.000512	0.00146	CcSEcCtD
Protriptyline—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00051	0.00146	CcSEcCtD
Protriptyline—Tinnitus—Methotrexate—urinary bladder cancer	0.000509	0.00145	CcSEcCtD
Protriptyline—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000508	0.00145	CcSEcCtD
Protriptyline—Asthenia—Cisplatin—urinary bladder cancer	0.000507	0.00145	CcSEcCtD
Protriptyline—Dizziness—Fluorouracil—urinary bladder cancer	0.000493	0.00141	CcSEcCtD
Protriptyline—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000491	0.0014	CcSEcCtD
Protriptyline—SLC6A4—NRF2 pathway—UGT2B7—urinary bladder cancer	0.00049	0.0244	CbGpPWpGaD
Protriptyline—Diarrhoea—Cisplatin—urinary bladder cancer	0.000484	0.00138	CcSEcCtD
Protriptyline—Alopecia—Methotrexate—urinary bladder cancer	0.000482	0.00138	CcSEcCtD
Protriptyline—Vomiting—Gemcitabine—urinary bladder cancer	0.000482	0.00138	CcSEcCtD
Protriptyline—Rash—Gemcitabine—urinary bladder cancer	0.000478	0.00137	CcSEcCtD
Protriptyline—Dermatitis—Gemcitabine—urinary bladder cancer	0.000478	0.00136	CcSEcCtD
Protriptyline—Tinnitus—Epirubicin—urinary bladder cancer	0.000476	0.00136	CcSEcCtD
Protriptyline—Headache—Gemcitabine—urinary bladder cancer	0.000475	0.00136	CcSEcCtD
Protriptyline—Flushing—Epirubicin—urinary bladder cancer	0.000474	0.00135	CcSEcCtD
Protriptyline—Vomiting—Fluorouracil—urinary bladder cancer	0.000474	0.00135	CcSEcCtD
Protriptyline—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00047	0.00134	CcSEcCtD
Protriptyline—Rash—Fluorouracil—urinary bladder cancer	0.00047	0.00134	CcSEcCtD
Protriptyline—Dermatitis—Fluorouracil—urinary bladder cancer	0.00047	0.00134	CcSEcCtD
Protriptyline—Headache—Fluorouracil—urinary bladder cancer	0.000467	0.00133	CcSEcCtD
Protriptyline—Dysgeusia—Methotrexate—urinary bladder cancer	0.000465	0.00133	CcSEcCtD
Protriptyline—Asthenia—Etoposide—urinary bladder cancer	0.000465	0.00133	CcSEcCtD
Protriptyline—Pruritus—Etoposide—urinary bladder cancer	0.000458	0.00131	CcSEcCtD
Protriptyline—Arrhythmia—Epirubicin—urinary bladder cancer	0.000456	0.0013	CcSEcCtD
Protriptyline—Alopecia—Epirubicin—urinary bladder cancer	0.000452	0.00129	CcSEcCtD
Protriptyline—Nausea—Gemcitabine—urinary bladder cancer	0.00045	0.00129	CcSEcCtD
Protriptyline—Vomiting—Cisplatin—urinary bladder cancer	0.000449	0.00128	CcSEcCtD
Protriptyline—Vision blurred—Methotrexate—urinary bladder cancer	0.000448	0.00128	CcSEcCtD
Protriptyline—Rash—Cisplatin—urinary bladder cancer	0.000446	0.00127	CcSEcCtD
Protriptyline—Dermatitis—Cisplatin—urinary bladder cancer	0.000445	0.00127	CcSEcCtD
Protriptyline—Diarrhoea—Etoposide—urinary bladder cancer	0.000443	0.00127	CcSEcCtD
Protriptyline—Nausea—Fluorouracil—urinary bladder cancer	0.000443	0.00126	CcSEcCtD
Protriptyline—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000441	0.00126	CcSEcCtD
Protriptyline—Tinnitus—Doxorubicin—urinary bladder cancer	0.000441	0.00126	CcSEcCtD
Protriptyline—Flushing—Doxorubicin—urinary bladder cancer	0.000439	0.00125	CcSEcCtD
Protriptyline—Dysgeusia—Epirubicin—urinary bladder cancer	0.000436	0.00124	CcSEcCtD
Protriptyline—Malaise—Methotrexate—urinary bladder cancer	0.000429	0.00122	CcSEcCtD
Protriptyline—Dizziness—Etoposide—urinary bladder cancer	0.000428	0.00122	CcSEcCtD
Protriptyline—Leukopenia—Methotrexate—urinary bladder cancer	0.000425	0.00121	CcSEcCtD
Protriptyline—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000422	0.00121	CcSEcCtD
Protriptyline—SLC6A2—NRF2 pathway—UGT2B7—urinary bladder cancer	0.000421	0.021	CbGpPWpGaD
Protriptyline—Nausea—Cisplatin—urinary bladder cancer	0.00042	0.0012	CcSEcCtD
Protriptyline—Vision blurred—Epirubicin—urinary bladder cancer	0.000419	0.0012	CcSEcCtD
Protriptyline—Alopecia—Doxorubicin—urinary bladder cancer	0.000418	0.00119	CcSEcCtD
Protriptyline—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000413	0.00118	CcSEcCtD
Protriptyline—Convulsion—Methotrexate—urinary bladder cancer	0.000412	0.00118	CcSEcCtD
Protriptyline—Vomiting—Etoposide—urinary bladder cancer	0.000412	0.00118	CcSEcCtD
Protriptyline—Agitation—Epirubicin—urinary bladder cancer	0.000409	0.00117	CcSEcCtD
Protriptyline—Rash—Etoposide—urinary bladder cancer	0.000408	0.00117	CcSEcCtD
Protriptyline—Dermatitis—Etoposide—urinary bladder cancer	0.000408	0.00117	CcSEcCtD
Protriptyline—Headache—Etoposide—urinary bladder cancer	0.000406	0.00116	CcSEcCtD
Protriptyline—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000403	0.00115	CcSEcCtD
Protriptyline—Malaise—Epirubicin—urinary bladder cancer	0.000401	0.00115	CcSEcCtD
Protriptyline—Discomfort—Methotrexate—urinary bladder cancer	0.0004	0.00114	CcSEcCtD
Protriptyline—Leukopenia—Epirubicin—urinary bladder cancer	0.000398	0.00114	CcSEcCtD
Protriptyline—Palpitations—Epirubicin—urinary bladder cancer	0.000393	0.00112	CcSEcCtD
Protriptyline—Confusional state—Methotrexate—urinary bladder cancer	0.000391	0.00112	CcSEcCtD
Protriptyline—Vision blurred—Doxorubicin—urinary bladder cancer	0.000388	0.00111	CcSEcCtD
Protriptyline—Convulsion—Epirubicin—urinary bladder cancer	0.000385	0.0011	CcSEcCtD
Protriptyline—Nausea—Etoposide—urinary bladder cancer	0.000385	0.0011	CcSEcCtD
Protriptyline—Hypertension—Epirubicin—urinary bladder cancer	0.000384	0.0011	CcSEcCtD
Protriptyline—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000382	0.00109	CcSEcCtD
Protriptyline—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00038	0.00108	CcSEcCtD
Protriptyline—Agitation—Doxorubicin—urinary bladder cancer	0.000378	0.00108	CcSEcCtD
Protriptyline—Anxiety—Epirubicin—urinary bladder cancer	0.000377	0.00108	CcSEcCtD
Protriptyline—Discomfort—Epirubicin—urinary bladder cancer	0.000374	0.00107	CcSEcCtD
Protriptyline—Malaise—Doxorubicin—urinary bladder cancer	0.000371	0.00106	CcSEcCtD
Protriptyline—Dry mouth—Epirubicin—urinary bladder cancer	0.00037	0.00106	CcSEcCtD
Protriptyline—Anorexia—Methotrexate—urinary bladder cancer	0.00037	0.00106	CcSEcCtD
Protriptyline—Leukopenia—Doxorubicin—urinary bladder cancer	0.000368	0.00105	CcSEcCtD
Protriptyline—Confusional state—Epirubicin—urinary bladder cancer	0.000366	0.00105	CcSEcCtD
Protriptyline—Palpitations—Doxorubicin—urinary bladder cancer	0.000364	0.00104	CcSEcCtD
Protriptyline—Oedema—Epirubicin—urinary bladder cancer	0.000363	0.00104	CcSEcCtD
Protriptyline—Hypotension—Methotrexate—urinary bladder cancer	0.000362	0.00104	CcSEcCtD
Protriptyline—Convulsion—Doxorubicin—urinary bladder cancer	0.000357	0.00102	CcSEcCtD
Protriptyline—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000355	0.00102	CcSEcCtD
Protriptyline—Hypertension—Doxorubicin—urinary bladder cancer	0.000355	0.00101	CcSEcCtD
Protriptyline—Tachycardia—Epirubicin—urinary bladder cancer	0.000354	0.00101	CcSEcCtD
Protriptyline—SLC6A4—Circadian rythm related genes—KMT2A—urinary bladder cancer	0.000353	0.0176	CbGpPWpGaD
Protriptyline—Insomnia—Methotrexate—urinary bladder cancer	0.000351	0.001	CcSEcCtD
Protriptyline—Anxiety—Doxorubicin—urinary bladder cancer	0.000349	0.000997	CcSEcCtD
Protriptyline—Paraesthesia—Methotrexate—urinary bladder cancer	0.000348	0.000995	CcSEcCtD
Protriptyline—Discomfort—Doxorubicin—urinary bladder cancer	0.000346	0.000989	CcSEcCtD
Protriptyline—Anorexia—Epirubicin—urinary bladder cancer	0.000346	0.000988	CcSEcCtD
Protriptyline—Somnolence—Methotrexate—urinary bladder cancer	0.000345	0.000985	CcSEcCtD
Protriptyline—Dry mouth—Doxorubicin—urinary bladder cancer	0.000343	0.000979	CcSEcCtD
Protriptyline—Dyspepsia—Methotrexate—urinary bladder cancer	0.000341	0.000975	CcSEcCtD
Protriptyline—Hypotension—Epirubicin—urinary bladder cancer	0.000339	0.000969	CcSEcCtD
Protriptyline—Confusional state—Doxorubicin—urinary bladder cancer	0.000339	0.000967	CcSEcCtD
Protriptyline—Decreased appetite—Methotrexate—urinary bladder cancer	0.000337	0.000963	CcSEcCtD
Protriptyline—Oedema—Doxorubicin—urinary bladder cancer	0.000336	0.000959	CcSEcCtD
Protriptyline—Fatigue—Methotrexate—urinary bladder cancer	0.000334	0.000955	CcSEcCtD
Protriptyline—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000329	0.000939	CcSEcCtD
Protriptyline—Insomnia—Epirubicin—urinary bladder cancer	0.000328	0.000938	CcSEcCtD
Protriptyline—Tachycardia—Doxorubicin—urinary bladder cancer	0.000328	0.000936	CcSEcCtD
Protriptyline—Paraesthesia—Epirubicin—urinary bladder cancer	0.000326	0.000931	CcSEcCtD
Protriptyline—Somnolence—Epirubicin—urinary bladder cancer	0.000323	0.000922	CcSEcCtD
Protriptyline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000321	0.016	CbGpPWpGaD
Protriptyline—Anorexia—Doxorubicin—urinary bladder cancer	0.00032	0.000914	CcSEcCtD
Protriptyline—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00032	0.000913	CcSEcCtD
Protriptyline—Dyspepsia—Epirubicin—urinary bladder cancer	0.00032	0.000913	CcSEcCtD
Protriptyline—CYP2D6—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000317	0.0158	CbGpPWpGaD
Protriptyline—Decreased appetite—Epirubicin—urinary bladder cancer	0.000316	0.000901	CcSEcCtD
Protriptyline—Hypotension—Doxorubicin—urinary bladder cancer	0.000314	0.000896	CcSEcCtD
Protriptyline—Fatigue—Epirubicin—urinary bladder cancer	0.000313	0.000894	CcSEcCtD
Protriptyline—Constipation—Epirubicin—urinary bladder cancer	0.00031	0.000887	CcSEcCtD
Protriptyline—Urticaria—Methotrexate—urinary bladder cancer	0.000308	0.00088	CcSEcCtD
Protriptyline—Abdominal pain—Methotrexate—urinary bladder cancer	0.000307	0.000876	CcSEcCtD
Protriptyline—Body temperature increased—Methotrexate—urinary bladder cancer	0.000307	0.000876	CcSEcCtD
Protriptyline—Insomnia—Doxorubicin—urinary bladder cancer	0.000304	0.000868	CcSEcCtD
Protriptyline—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000302	0.000861	CcSEcCtD
Protriptyline—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000299	0.000854	CcSEcCtD
Protriptyline—Somnolence—Doxorubicin—urinary bladder cancer	0.000299	0.000853	CcSEcCtD
Protriptyline—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000296	0.000844	CcSEcCtD
Protriptyline—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000292	0.000834	CcSEcCtD
Protriptyline—SLC6A2—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00029	0.0145	CbGpPWpGaD
Protriptyline—Fatigue—Doxorubicin—urinary bladder cancer	0.00029	0.000827	CcSEcCtD
Protriptyline—Urticaria—Epirubicin—urinary bladder cancer	0.000288	0.000824	CcSEcCtD
Protriptyline—Constipation—Doxorubicin—urinary bladder cancer	0.000287	0.00082	CcSEcCtD
Protriptyline—Abdominal pain—Epirubicin—urinary bladder cancer	0.000287	0.00082	CcSEcCtD
Protriptyline—Body temperature increased—Epirubicin—urinary bladder cancer	0.000287	0.00082	CcSEcCtD
Protriptyline—Asthenia—Methotrexate—urinary bladder cancer	0.000278	0.000795	CcSEcCtD
Protriptyline—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000277	0.00079	CcSEcCtD
Protriptyline—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000275	0.0137	CbGpPWpGaD
Protriptyline—Pruritus—Methotrexate—urinary bladder cancer	0.000274	0.000784	CcSEcCtD
Protriptyline—Urticaria—Doxorubicin—urinary bladder cancer	0.000267	0.000762	CcSEcCtD
Protriptyline—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000266	0.000758	CcSEcCtD
Protriptyline—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000266	0.000758	CcSEcCtD
Protriptyline—Diarrhoea—Methotrexate—urinary bladder cancer	0.000265	0.000758	CcSEcCtD
Protriptyline—Asthenia—Epirubicin—urinary bladder cancer	0.00026	0.000744	CcSEcCtD
Protriptyline—CYP2D6—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00026	0.0129	CbGpPWpGaD
Protriptyline—Pruritus—Epirubicin—urinary bladder cancer	0.000257	0.000733	CcSEcCtD
Protriptyline—Dizziness—Methotrexate—urinary bladder cancer	0.000257	0.000733	CcSEcCtD
Protriptyline—Diarrhoea—Epirubicin—urinary bladder cancer	0.000248	0.000709	CcSEcCtD
Protriptyline—Vomiting—Methotrexate—urinary bladder cancer	0.000247	0.000704	CcSEcCtD
Protriptyline—Rash—Methotrexate—urinary bladder cancer	0.000245	0.000698	CcSEcCtD
Protriptyline—Dermatitis—Methotrexate—urinary bladder cancer	0.000244	0.000698	CcSEcCtD
Protriptyline—Headache—Methotrexate—urinary bladder cancer	0.000243	0.000694	CcSEcCtD
Protriptyline—Asthenia—Doxorubicin—urinary bladder cancer	0.000241	0.000688	CcSEcCtD
Protriptyline—Dizziness—Epirubicin—urinary bladder cancer	0.00024	0.000686	CcSEcCtD
Protriptyline—Pruritus—Doxorubicin—urinary bladder cancer	0.000238	0.000679	CcSEcCtD
Protriptyline—Vomiting—Epirubicin—urinary bladder cancer	0.000231	0.000659	CcSEcCtD
Protriptyline—Nausea—Methotrexate—urinary bladder cancer	0.00023	0.000658	CcSEcCtD
Protriptyline—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00023	0.000656	CcSEcCtD
Protriptyline—Rash—Epirubicin—urinary bladder cancer	0.000229	0.000654	CcSEcCtD
Protriptyline—Dermatitis—Epirubicin—urinary bladder cancer	0.000229	0.000653	CcSEcCtD
Protriptyline—Headache—Epirubicin—urinary bladder cancer	0.000227	0.000649	CcSEcCtD
Protriptyline—Dizziness—Doxorubicin—urinary bladder cancer	0.000222	0.000634	CcSEcCtD
Protriptyline—Nausea—Epirubicin—urinary bladder cancer	0.000216	0.000616	CcSEcCtD
Protriptyline—Vomiting—Doxorubicin—urinary bladder cancer	0.000214	0.00061	CcSEcCtD
Protriptyline—Rash—Doxorubicin—urinary bladder cancer	0.000212	0.000605	CcSEcCtD
Protriptyline—Dermatitis—Doxorubicin—urinary bladder cancer	0.000212	0.000604	CcSEcCtD
Protriptyline—Headache—Doxorubicin—urinary bladder cancer	0.00021	0.000601	CcSEcCtD
Protriptyline—Nausea—Doxorubicin—urinary bladder cancer	0.0002	0.00057	CcSEcCtD
Protriptyline—SLC6A4—NRF2 pathway—NQO1—urinary bladder cancer	0.000189	0.00942	CbGpPWpGaD
Protriptyline—SLC6A4—Monoamine Transport—TNF—urinary bladder cancer	0.000186	0.00925	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.000178	0.00887	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—GSTZ1—urinary bladder cancer	0.000177	0.00881	CbGpPWpGaD
Protriptyline—CYP2D6—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000174	0.00869	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—GSTO2—urinary bladder cancer	0.000168	0.00835	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—NAT1—urinary bladder cancer	0.000168	0.00835	CbGpPWpGaD
Protriptyline—CYP2D6—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000165	0.00823	CbGpPWpGaD
Protriptyline—SLC6A2—NRF2 pathway—NQO1—urinary bladder cancer	0.000163	0.0081	CbGpPWpGaD
Protriptyline—SLC6A2—Monoamine Transport—TNF—urinary bladder cancer	0.00016	0.00796	CbGpPWpGaD
Protriptyline—SLC6A4—NRF2 pathway—GSTP1—urinary bladder cancer	0.000158	0.00785	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—UGT2B7—urinary bladder cancer	0.000153	0.00764	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—TFRC—urinary bladder cancer	0.000152	0.00759	CbGpPWpGaD
Protriptyline—CYP2D6—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000151	0.00753	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000148	0.00735	CbGpPWpGaD
Protriptyline—SLC6A4—NRF2 pathway—GSTM1—urinary bladder cancer	0.000145	0.00722	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—CYP4B1—urinary bladder cancer	0.000138	0.00687	CbGpPWpGaD
Protriptyline—CYP2D6—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000136	0.00678	CbGpPWpGaD
Protriptyline—SLC6A2—NRF2 pathway—GSTP1—urinary bladder cancer	0.000136	0.00675	CbGpPWpGaD
Protriptyline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000126	0.00628	CbGpPWpGaD
Protriptyline—SLC6A2—NRF2 pathway—GSTM1—urinary bladder cancer	0.000125	0.00621	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—TYMS—urinary bladder cancer	0.000114	0.00565	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.000112	0.00559	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000107	0.00531	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—FAS—urinary bladder cancer	0.000101	0.00501	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	9.47e-05	0.00471	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	9.4e-05	0.00468	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—NAT2—urinary bladder cancer	9.19e-05	0.00457	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	9.13e-05	0.00455	CbGpPWpGaD
Protriptyline—CYP2D6—Metapathway biotransformation—NAT2—urinary bladder cancer	9.06e-05	0.00451	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—CDK4—urinary bladder cancer	8.86e-05	0.00441	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	8.7e-05	0.00433	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—PPARG—urinary bladder cancer	8.05e-05	0.00401	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	8.05e-05	0.004	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	7.52e-05	0.00374	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	7.35e-05	0.00366	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	7.17e-05	0.00357	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	7.13e-05	0.00355	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	7.13e-05	0.00355	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	7.12e-05	0.00355	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	6.5e-05	0.00323	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	6.45e-05	0.00321	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.88e-05	0.00292	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	5.74e-05	0.00286	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—PTEN—urinary bladder cancer	5.52e-05	0.00275	CbGpPWpGaD
Protriptyline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	5.37e-05	0.00267	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—EP300—urinary bladder cancer	5.26e-05	0.00262	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	5.23e-05	0.00261	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	4.94e-05	0.00246	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	4.91e-05	0.00244	CbGpPWpGaD
Protriptyline—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	4.87e-05	0.00242	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	4.86e-05	0.00242	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	4.7e-05	0.00234	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	4.69e-05	0.00233	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	4.56e-05	0.00227	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	4.54e-05	0.00226	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	4.48e-05	0.00223	CbGpPWpGaD
Protriptyline—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.48e-05	0.00223	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	3.97e-05	0.00198	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	3.83e-05	0.00191	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—TP53—urinary bladder cancer	3.77e-05	0.00188	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	3.51e-05	0.00175	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	3.49e-05	0.00174	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	3.48e-05	0.00173	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	3.42e-05	0.0017	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	3.21e-05	0.0016	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	3.05e-05	0.00152	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—NAT1—urinary bladder cancer	3.04e-05	0.00152	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—GSTO2—urinary bladder cancer	3.04e-05	0.00152	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	3.03e-05	0.00151	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	3.01e-05	0.0015	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	2.87e-05	0.00143	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—NAT1—urinary bladder cancer	2.87e-05	0.00143	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	2.78e-05	0.00139	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.75e-05	0.00137	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	2.62e-05	0.00131	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.59e-05	0.00129	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	2.55e-05	0.00127	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	2.51e-05	0.00125	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	2.5e-05	0.00124	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	2.37e-05	0.00118	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	2.36e-05	0.00118	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PRSS3—urinary bladder cancer	2.31e-05	0.00115	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.26e-05	0.00112	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	2.23e-05	0.00111	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.18e-05	0.00109	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.18e-05	0.00108	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	2.17e-05	0.00108	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.08e-05	0.00103	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.02e-05	0.00101	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—TYMP—urinary bladder cancer	1.84e-05	0.000918	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.81e-05	0.000901	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.77e-05	0.000881	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—TYMP—urinary bladder cancer	1.74e-05	0.000865	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.69e-05	0.000839	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.67e-05	0.000832	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.67e-05	0.00083	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—NAT2—urinary bladder cancer	1.57e-05	0.000782	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.49e-05	0.00074	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.44e-05	0.000717	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.36e-05	0.000675	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.33e-05	0.000664	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.33e-05	0.000664	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.29e-05	0.000644	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.26e-05	0.000625	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.26e-05	0.000625	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.22e-05	0.000607	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.21e-05	0.000603	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.07e-05	0.000535	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.01e-05	0.000504	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—GSTP1—urinary bladder cancer	8.96e-06	0.000446	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	8.45e-06	0.00042	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—TYMS—urinary bladder cancer	8.33e-06	0.000415	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—GSTM1—urinary bladder cancer	8.24e-06	0.00041	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—NCOR1—urinary bladder cancer	8.24e-06	0.00041	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—GPX1—urinary bladder cancer	7.89e-06	0.000393	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—TYMS—urinary bladder cancer	7.85e-06	0.000391	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	7.76e-06	0.000386	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	7.76e-06	0.000386	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—ERCC2—urinary bladder cancer	7.74e-06	0.000385	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—GPX1—urinary bladder cancer	7.43e-06	0.00037	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	7.3e-06	0.000363	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—MTHFR—urinary bladder cancer	7.28e-06	0.000362	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	6.86e-06	0.000341	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PPARG—urinary bladder cancer	5.9e-06	0.000294	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—CREBBP—urinary bladder cancer	5.67e-06	0.000282	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PPARG—urinary bladder cancer	5.56e-06	0.000277	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	5.34e-06	0.000266	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PTGS2—urinary bladder cancer	4.64e-06	0.000231	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	4.38e-06	0.000218	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PTEN—urinary bladder cancer	4.05e-06	0.000202	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—EP300—urinary bladder cancer	3.86e-06	0.000192	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PTEN—urinary bladder cancer	3.82e-06	0.00019	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—EP300—urinary bladder cancer	3.64e-06	0.000181	CbGpPWpGaD
